THERAPEUTICS DEVELOPMENT NETWORK
Live / Registered — Registered (as of 25 Jan 2022)
What this means for you
Registered since 25 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90263220
- Registration number
- 6625347
- Mark type
- Stylized text
- Filed
- 19 Oct 2020
- Published for opposition
- 09 Nov 2021
- Registered
- 25 Jan 2022
- Attorney of record
- Jody H. Drake
Goods and services
- Class 035 — Advertising and business services: Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials
- Class 045 — Legal and security services: Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research
Owner
- Cystic Fibrosis Foundation, Washington, DC, US
- Cystic Fibrosis Foundation, Washington, DC, US
- Cystic Fibrosis Foundation, Washington, DC, US
Prosecution history
- 25 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 09 Nov 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Nov 2021 — PUBLISHED FOR OPPOSITION
- 20 Oct 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Oct 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Sept 2021 — ASSIGNED TO EXAMINER
- 20 Sept 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Sept 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Sept 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Mar 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Mar 2021 — NON-FINAL ACTION E-MAILED
- 19 Mar 2021 — NON-FINAL ACTION WRITTEN
- 18 Mar 2021 — ASSIGNED TO EXAMINER
- 06 Dec 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Oct 2020 — NEW APPLICATION ENTERED